NCT01139008

Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy Skin

Split-Face Tolerability Comparison Between MetroGel® (Metronidazole Gel) 1% Versus Finacea® (Azelaic Acid) Gel 15% in Subjects With Healthy Skin

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Galderma R&D · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the tolerability of MetroGel® (metronidazole gel) 1% to Finacea® (azelaic acid) Gel 15% in subjects with healthy skin applied according to product labeling for three weeks.

Conditions

• Skin Manifestations

Interventions

Type	Name	Description
DRUG	metronidazole 1% gel	Apply topically on one side of the face once daily for three weeks
DRUG	azelaic acid 15% gel	Apply topically on the opposite side of the face twice daily for three weeks

Timeline

• Start date: 2010-06-01
• Primary completion: 2010-06-01
• Completion: 2010-06-01
• First posted: 2010-06-08
• Last updated: 2022-08-01
• Results posted: 2011-07-26

Locations

1 site across 1 country: United States